© Messe Düsseldorf The inside of a laboratory automat
13:0013:20 18. Nov 2019
13:0013:20 18. Nov 2019 iCal myOrganizer
MEDICA LABMED FORUM

MLF: DPP: The new platform for multiplex testing at POC

Session Advances in clinical microbiology and infectious diseases

Chembio is a leading point-of-care diagnostics company focused on detecting and diagnosing infectious diseases. The company’s patented DPP technology platform, which uses a small drop of blood from the fingertip, provides high-quality, cost-effective results in approximately 15 minutes. Coupled with Chembio’s extensive scientific expertise, its novel DPP technology offers broad market applications beyond infectious disease, a number of which applications are under active development with collaboration partners. Chembio’s products are sold globally, directly and through distributors, to hospitals and clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers. Learn more at www.chembio.com.